2,836
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Reduced duration and dosage of venetoclax is efficient in newly diagnosed patients with acute myeloid leukemia

, , , &
Article: 2293512 | Received 27 Jun 2023, Accepted 02 Dec 2023, Published online: 14 Dec 2023

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.